Clinical Trials

Company-Supported Clinical Trials

Key clinical trials sponsored by Mallinckrodt for branded drugs are listed on www.clinicaltrials.gov and detailed below, with a link provided to learn more and an indicator of the current phase of development.

Study Title PHASE
1
PHASE
2
PHASE
3
PHASE
4
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
More Information >
    X  
A STUDY TO EVALUATE THE DRUG-DRUG INTERACTIONS BETWEEN MORPHINE AND ORALLY OR IV ADMINISTERED ACETAMINOPHEN
More Information >
      X
A study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
More Information >
  X    
A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease
More Information >
  X    
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients (CHART)
More Information >
      X
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
More Information >
  X    
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
More Information >
      X
Safety and Efficacy Study of Hydromorphone HCL by Intrathecal Administration Using a Programmable Implantable Pump
More Information >
    X  
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
More Information >
    X  
Single-arm Study to Assess the Safety of Hydromorphone HCL by Intrathecal Administration
More Information >
    X  
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS (PODOCYTE)
More Information >
      X
UVADEX® and ECP for the Treatment of Pediatric Patients With Steroid Refractory Acute Graft Versus Host Disease
More Information >
    X